Literature DB >> 28017184

Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement.

Scott P Stumbo1, Bobbi Jo H Yarborough2, Dennis McCarty3, Constance Weisner4, Carla A Green5.   

Abstract

BACKGROUND: Risk factors associated with developing opioid use disorders (OUD) are documented, but less is known about different pathways to initiation of opioids or opioid dependence, or how such pathways affect treatment engagement.
METHODS: We recruited 283 adults with electronic medical record (EMR) evidence of opioid dependence diagnoses. Open-ended and structured interview items focused on prior opioid treatment experiences, barriers to and knowledge of treatment options. Interviews were audio-recorded, transcribed, and coded. In exploratory analyses, we used a modified grounded theory approach to organize emergent, patient-reported themes describing participants' perceived pathways to opioid dependence.
RESULTS: 121 participants described one or more pathways to OUD. Qualitative analyses revealed five pathway themes. Three pathways were related to pain control: inadequately controlled chronic pain, exposure to opioids during acute pain episodes, and chronic pain among individuals with prior substance use disorders. A fourth pathway included individuals for whom opioids provided relief from emotional distress; the fifth related to recreational or non-medically supervised opioid use. We identified pain-related barriers to reducing/stopping opioids and treatment engagement barriers among individuals who perceived themselves solely as pain patients.
CONCLUSION: Patients' perceptions of inadequately controlled pain, patients' previous substance use disorders, and the relief from emotional distress that some patients feel while using opioids are relevant when making clinical decisions about whether to initiate or sustain opioid therapy, and for how to monitor certain individuals. Among individuals with pain and OUD, treatment barriers include fear of uncontrolled pain, and stigmatization of being treated alongside people with non-medical opioid use.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emotional distress; Opioid addiction treatment; Opioid use disorder; Qualitative research; Stigma; Treatment barriers

Mesh:

Year:  2016        PMID: 28017184      PMCID: PMC5193128          DOI: 10.1016/j.jsat.2016.11.003

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  40 in total

Review 1.  Opioid tolerance and hyperalgesia.

Authors:  Grace Chang; Lucy Chen; Jianren Mao
Journal:  Med Clin North Am       Date:  2007-03       Impact factor: 5.456

2.  Nurses' Role in Preventing Prescription Opioid Diversion.

Authors:  Renee C B Manworren; Aaron M Gilson
Journal:  Am J Nurs       Date:  2015-08       Impact factor: 2.220

3.  Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.

Authors:  Leonard J Paulozzi; Gail K Strickler; Peter W Kreiner; Caitlin M Koris
Journal:  MMWR Surveill Summ       Date:  2015-10-16

4.  Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals.

Authors:  Bryan N Cochran; Annesa Flentje; Nicholas C Heck; Jill Van Den Bos; Dan Perlman; Jorge Torres; Robert Valuck; Jean Carter
Journal:  Drug Alcohol Depend       Date:  2014-03-12       Impact factor: 4.492

5.  Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence.

Authors:  Kelly S Barth; Megan Moran-Santa Maria; Katie Lawson; Stephanie Shaftman; Kathleen T Brady; Sudie E Back
Journal:  Am J Addict       Date:  2013-05-15

6.  "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.

Authors:  Adam R Winstock; Nicholas Lintzeris; Toby Lea
Journal:  Int J Drug Policy       Date:  2010-10-16

7.  Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; Margaret L Griffin; R Kathryn McHugh; Deborah Haller; Petra Jacobs; John Gardin; Dan Fischer; Kristen D Rosen
Journal:  J Subst Abuse Treat       Date:  2014-04-04

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

9.  Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012.

Authors:  Leonard J Paulozzi; Karin A Mack; Jason M Hockenberry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-04       Impact factor: 17.586

10.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.

Authors:  Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-10       Impact factor: 17.586

View more
  28 in total

Review 1.  Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain.

Authors:  Esad Ulker; Egidio Del Fabbro
Journal:  Oncologist       Date:  2019-12-24

2.  Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.

Authors:  Elizabeth C Saunders; Sarah K Moore; Olivia Walsh; Stephen A Metcalf; Alan J Budney; Emily Scherer; Lisa A Marsch
Journal:  J Subst Abuse Treat       Date:  2020-01-21

3.  Opioid Use among Individuals with Traumatic Brain Injury: A Perfect Storm?

Authors:  Rachel Sayko Adams; John D Corrigan; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2019-08-16       Impact factor: 5.269

4.  Taking opioids in times of crisis: Institutional oversight, chronic pain and suffering in an integrated healthcare delivery system in the U.S.

Authors:  Inga Gruß; Alison Firemark; Meghan Mayhew; Carmit K McMullen; Lynn L DeBar
Journal:  Int J Drug Policy       Date:  2019-09-16

5.  A supportive school environment may reduce the risk of non-medical prescription opioid use due to impaired mental health among students.

Authors:  Charlotte Probst; Tara Elton-Marshall; Sameer Imtiaz; Karen A Patte; Jürgen Rehm; Bundit Sornpaisarn; Scott T Leatherdale
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-03-25       Impact factor: 4.785

Review 6.  Psychiatry and Pain Management: at the Intersection of Chronic Pain and Mental Health.

Authors:  Jenna Goesling; Lewei A Lin; Daniel J Clauw
Journal:  Curr Psychiatry Rep       Date:  2018-03-05       Impact factor: 5.285

Review 7.  Recommendations for Substance Abuse and Pain Control in Patients with Chronic Pain.

Authors:  Nalini Vadivelu; Alice M Kai; Gopal Kodumudi; Dan Haddad; Vijay Kodumudi; Niketh Kuruvilla; Alan David Kaye; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

Review 8.  Psychiatry and the Opioid Overdose Crisis.

Authors:  Bertha K Madras; Hilary Connery
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-04-10

9.  Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization.

Authors:  William S John; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2020-02-11       Impact factor: 4.492

10.  Opioid Prescribing for Opioid-Naive Patients in Emergency Departments and Other Settings: Characteristics of Prescriptions and Association With Long-Term Use.

Authors:  Molly Moore Jeffery; W Michael Hooten; Erik P Hess; Ellen R Meara; Joseph S Ross; Henry J Henk; Bjug Borgundvaag; Nilay D Shah; M Fernanda Bellolio
Journal:  Ann Emerg Med       Date:  2017-09-26       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.